← FDA Drug Approvals (Drugs@FDA)

LORATADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2023-03-24

Drug application

FDA Application #

ANDA211900

Application type

Abbreviated New Drug Application (Generic)

Brand name

LORATADINE

Generic name

LORATADINE

Active ingredients

LORATADINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Over-the-counter

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurohealth LLC

First approval

2023-03-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown